ELV 📈 Elevance Health - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0367521038
ELV: Health Insurance, Pharmacy Services, Managed Care, Wellness Programs
Elevance Health, Inc. is a prominent health benefits company in the United States, operating through a diverse range of segments, including Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. This multifaceted approach enables the company to offer a broad spectrum of health plans and services to its program members, as well as an array of fee-based administrative managed care services. Additionally, the company provides specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits, catering to the varied needs of its customers.
The company's operations extend to the pharmacy services business, where it markets and offers an extensive range of services, including pharmacy benefit management, home delivery, and specialty pharmacies. Furthermore, it provides claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, demonstrating its commitment to comprehensive healthcare solutions. Elevance Health, Inc. also delivers healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, underscoring its focus on holistic care.
In addition to its core services, the company is involved in the National Government Services business, providing services under the esteemed Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. With a history dating back to 2001, Elevance Health, Inc. has established itself as a trusted entity in the healthcare industry, with its headquarters located in Indianapolis, Indiana. The company's evolution is marked by its name change from Anthem, Inc. to Elevance Health, Inc. in June 2022, reflecting its growth and expansion into new areas of healthcare. As a publicly traded company, Elevance Health, Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol ELV, with its common stock classified under the GICS Sub Industry of Managed Health Care.
Additional Sources for ELV Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ELV Stock Overview
Market Cap in USD | 86,577m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC Sub-Industry | Managed Health Care |
IPO / Inception | 2001-01-02 |
ELV Stock Ratings
Growth 5y | 34.8% |
Fundamental | 39.7% |
Dividend | 65.9% |
Rel. Strength Industry | -1844 |
Analysts | 4.45/5 |
Fair Price Momentum | 331.33 USD |
Fair Price DCF | 97.16 USD |
ELV Dividends
Dividend Yield 12m | 1.71% |
Yield on Cost 5y | 2.25% |
Annual Growth 5y | 11.40% |
Payout Consistency | 100.0% |
ELV Growth Ratios
Growth Correlation 3m | -93.3% |
Growth Correlation 12m | -26.1% |
Growth Correlation 5y | 80.1% |
CAGR 5y | 5.65% |
CAGR/Mean DD 5y | 0.63 |
Sharpe Ratio 12m | -1.04 |
Alpha | -46.35 |
Beta | 1.02 |
Volatility | 27.74% |
Current Volume | 1190.6k |
Average Volume 20d | 1808.3k |
As of January 08, 2025, the stock is trading at USD 380.75 with a total of 1,190,556 shares traded.
Over the past week, the price has changed by +3.21%, over one month by -3.77%, over three months by -22.30% and over the past year by -19.62%.
Partly, yes. Based on ValueRay Fundamental Analyses, Elevance Health (NYSE:ELV) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 39.71 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ELV as of January 2025 is 331.33. This means that ELV is currently overvalued and has a potential downside of -12.98%.
Elevance Health has received a consensus analysts rating of 4.45. Therefor, it is recommend to buy ELV.
- Strong Buy: 13
- Buy: 6
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ELV Elevance Health will be worth about 363 in January 2026. The stock is currently trading at 380.75. This means that the stock has a potential downside of -4.66%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 516.7 | 35.7% |
Analysts Target Price | 570 | 49.7% |
ValueRay Target Price | 363 | -4.7% |